QLGN logo

Qualigen Therapeutics (QLGN) Operating Profit

Annual Operating Profit

-$11.30 M
+$3.46 M+23.41%

31 December 2023

QLGN Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Profit

-$1.27 M
+$472.20 K+27.13%

30 September 2024

QLGN Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Operating Profit

-$6.71 M
+$1.51 M+18.38%

30 September 2024

QLGN TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

QLGN Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+44.2%+40.7%
3 y3 years+50.1%+72.7%+70.4%
5 y5 years--338.1%-722.7%

QLGN Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+50.1%at high+74.7%at high+70.4%
5 y5 years-7.5%+50.1%-338.1%+82.8%-722.7%+70.4%
alltimeall time-7.5%+50.1%-338.1%+82.8%-1176.2%+70.4%

Qualigen Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
-$1.27 M(-27.1%)
-$6.71 M(-18.4%)
June 2024
-
-$1.74 M(+22.4%)
-$8.21 M(-18.5%)
Mar 2024
-
-$1.42 M(-37.5%)
-$10.08 M(-10.9%)
Dec 2023
-$11.30 M(-23.4%)
-$2.27 M(-18.2%)
-$11.30 M(-9.3%)
Sept 2023
-
-$2.78 M(-22.9%)
-$12.47 M(-5.3%)
June 2023
-
-$3.60 M(+35.9%)
-$13.16 M(-3.9%)
Mar 2023
-
-$2.65 M(-22.9%)
-$13.70 M(-14.7%)
Dec 2022
-$14.76 M
-$3.44 M(-1.0%)
-$16.06 M(-7.0%)
Sept 2022
-
-$3.47 M(-16.2%)
-$17.27 M(-7.2%)
June 2022
-
-$4.14 M(-17.3%)
-$18.61 M(-14.9%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$5.01 M(+7.8%)
-$21.86 M(-3.5%)
Dec 2021
-$22.66 M(+115.4%)
-$4.65 M(-3.3%)
-$22.66 M(+25.8%)
Sept 2021
-
-$4.81 M(-35.0%)
-$18.02 M(+6.4%)
June 2021
-
-$7.39 M(+27.2%)
-$16.93 M(+39.9%)
Mar 2021
-
-$5.81 M(+56.4%)
-$12.10 M(+92.5%)
Dec 2020
-$10.52 M
-
-
Sept 2020
-
-$3.72 M(+44.7%)
-$6.29 M(+119.9%)
June 2020
-
-$2.57 M(+787.3%)
-$2.86 M(+250.8%)
Sept 2019
-
-$289.60 K(-44.9%)
-$815.00 K(+55.1%)
June 2019
-
-$525.40 K
-$525.40 K

FAQ

  • What is Qualigen Therapeutics annual operaing income?
  • What is the all time high annual operating profit for Qualigen Therapeutics?
  • What is Qualigen Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Qualigen Therapeutics?
  • What is Qualigen Therapeutics quarterly operating profit year-on-year change?
  • What is Qualigen Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Qualigen Therapeutics?
  • What is Qualigen Therapeutics TTM operating profit year-on-year change?

What is Qualigen Therapeutics annual operaing income?

The current annual operating profit of QLGN is -$11.30 M

What is the all time high annual operating profit for Qualigen Therapeutics?

Qualigen Therapeutics all-time high annual operaing income is -$10.52 M

What is Qualigen Therapeutics quarterly operating income?

The current quarterly operating profit of QLGN is -$1.27 M

What is the all time high quarterly operating profit for Qualigen Therapeutics?

Qualigen Therapeutics all-time high quarterly operating income is -$289.60 K

What is Qualigen Therapeutics quarterly operating profit year-on-year change?

Over the past year, QLGN quarterly operating income has changed by +$1.01 M (+44.21%)

What is Qualigen Therapeutics TTM operating income?

The current TTM operating profit of QLGN is -$6.71 M

What is the all time high TTM operating profit for Qualigen Therapeutics?

Qualigen Therapeutics all-time high TTM operating income is -$525.40 K

What is Qualigen Therapeutics TTM operating profit year-on-year change?

Over the past year, QLGN TTM operating income has changed by +$4.60 M (+40.69%)